The DOI matches its Crossref record; 93 of the 95 references it cites were found in a registry or an index.
Clonal Hematopoiesis: Mechanisms Driving Dominance of Stem Cell Clones
Open accessAbstract
The discovery of clonal hematopoiesis (CH) in older individuals has changed the way hematologists and stem cell biologists view aging. Somatic mutations accumulate in stem cells over time. While most mutations have no impact, some result in subtle functional differences that ultimately manifest in distinct stem cell behaviors. With a large pool of stem cells and many decades to compete, some of these differences confer advantages under specific contexts. About 20 genes are recurrently found as mutated in CH, indicating they confer some advantage. The impact of these mutations has begun to be analyzed at a molecular level by modeling in cell lines and in mice. Mutations in epigenetic regulators such as DNMT3A and TET2 confer an advantage by enhancing self-renewal of stem and progenitor cells and inhibiting their differentiation. Mutations in other genes involved in the DNA damage response may simply enhance cell survival. Here, we review proposed mechanisms that lead to CH, specifically in the context of stem cell biology, based on our current understanding of the function of some of the CH-associated genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most DNMT3A variants in human CH are missense heterozygous loss-of-function (6).”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately 50% of all genetic variants in CH occur in the gene DNMT3A (6), which encodes a de novo DNA methyltransferase enzyme responsible for establishing new DNA methylation patterns during development and stem cell fate decisions (7,8).”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Couedic, J. P. L., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslová, H., Berger, R., Griscelli, A. B., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,542
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Ito, S., D’Alessio, A. C., Taranova, O., Hong, K., Sowers, L. C., & Zhang, Y. (2010) · Nature · doi:10.1038/nature09303 · Cited by 2,628
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
Flagged first, then by citations
2 of the 95 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Meyer SE, Qin T, Muench DE, et al. DNMT3A haploinsufficiency transforms FLT3ITD mye- loproliferative disease into a rapid, sponta- neous, and fully penetrant acute myeloid leukemia. Cancer Discov. 2016;6(5):501-515.
- Bondar T, Medzhitov R. p53-mediated he- matopoietic stem and progenitor cell com- petition. Cell Stem Cell. 2010;6(4):309-322.
Cited by
Sorted by citations
Items 101–130 of 130
Jotte, M. R. M., Stoddart, A., Martinez, T. C., Moten, R., Xue, Y., Imgruet, M. K., Blaylock, H. Z., Nam, H. S., Hu, B. Y., Austin, J., et al. (2025) · Blood Neoplasia · doi:10.1016/j.bneo.2025.100083 · Cited by 2
Targeted sequencing of candidate gene regions for myelofibrosis in dogs
Campbell, A. G., Seelig, D. M., Beckman, J. D., Minor, K. M., Heinrich, D. A., Friedenberg, S. G., Modiano, J. F., & Furrow, E. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16476 · Cited by 2
Murakami, S., Barroca, V., Perié, L., Bravard, A., Bernardino-Sgherri, J., Tisserand, A., Devanand, C., Edmond, V., Magniez, A., Bento, S. T., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0039 · Cited by 2
RetractedLv, H., Gao, Z., Wang, Y., Liu, P., Qin, D., Zhou, H., & Xu, Y. (2022) · PubMed Central · doi:10.2196/preprints.40618 · Cited by 2
Aging, Causes, and Rejuvenation of Hematopoietic Stem Cells
Chen, Z., Ju, Z., & Sun, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_12 · Cited by 1
Bueno, V. (2024) · Springer eBooks · doi:10.1007/978-3-031-55022-5_7 · Cited by 1
Can Ruxolitinib Crash TET2 - and IDH2 -Driven Clonal Hematopoiesis?
Khabusheva, E., & Goodell, M. A. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1020 · Cited by 1
Self-citationYoon, H., Park, S., Kwon, Y.-R., & Kim, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328922 · Cited by 1
Elucidating the risk factors and oncogene drivers of acute myeloid leukemia
Sanya, D. R. A., & Onésime, D. (2025) · Human Cell · doi:10.1007/s13577-025-01294-9 · Cited by 1
Ogura, R., Ito, S., Ueda, T., Gabata, Y., Sako, S., Inoue, Y., Yamada, T., Konishi, H., Fujihara, A., & Ukimura, O. (2023) · Scientific Reports · doi:10.1038/s41598-023-46977-1 · Cited by 1
Pathogenesis of diabetic atherosclerotic cardiovascular disease
Avogaro, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00019-1 · Cited by 1
Krishnan, A., Miles, L. A., & Challen, G. A. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104816 · Cited by 1
Self-citationBedeutung der klonalen Hämatopoese für hämatologische Neoplasien
Götze, K. S. S., & Lengerke, C. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01401-0 · Cited by 1
Genetic landscape of DNMT3A R882H reveals mechanism of aberrant oligomerizationPreprint
Garcia, E. M., Lavidor, O. R., Raval, S., Lue, N. Z., Liang, J. K., McFadden, M., Hwang, D. D., Zepeda, M. L., Chen, L. W., Carr, S. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.24.678339 · Cited by 2
Proteostasis Stress Drives Stem Cell Aging, Clonal Hematopoiesis and LeukemiaPreprint
Zhou, F., Le, M. K., Wang, H. C., Yang, W., Wang, H., Tiwari, A., Cen, X., Sunshine, M. J., Magee, J. A., & Signer, R. A. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.27.690982 · Cited by 1
COVID-19, Aging, and Progress Toward Hematological Malignancies or Cardiovascular Diseases
Ardestani, M. T., & Norouzian, M. (2022) · Disease and Diagnosis · doi:10.34172/ddj.2022.32
Xie, J., Sheng, M., Rong, S., Wang, C., Wu, W., Huang, J., Sun, Y., Chen, P., Wu, Y., Wang, Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.17.520899
Elfassy, E., & Gazit, R. (2023) · Blood · doi:10.1182/blood.2023019993
Blood-based screening panel for lung cancer based on clonal hematopoietic mutationsPreprint
Anandakrishnan, R., Shahidi, R., Dai, A., Antony, V., & Zyvoloski, I. J. (2023) · Research Square · doi:10.21203/rs.3.rs-3266804/v1
Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation MutagenesisPreprint
Demajo, S., Ramis-Zaldivar, J. E., Muiños, F., Grau, M. L., Andrianova, M. A., López-Bigas, N., & González-Pérez, A. (2023) · medRxiv · doi:10.1101/2023.12.13.23299893
Clonal hematopoiesis: a shared risk factor for cardiovascular diseases and tumors
Zha, L., & Cheng, X. C. (2024) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000029
Богданов, А. Н., Волошин, С. В., Куневич, Е. О., & Mikhaleva, M. (2024) · Успехи геронтологии · doi:10.34922/ae.2024.37.3.013
Prummel, K. D., Woods, K., Kholmatov, M. M., Schmitt, E. C., Vlachou, E. P., Poschmann, G., Stühler, K., Wehner, R., Schmitz, M., Winter, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.27.625734
Cypris, O., Franzen, J., Frobel, J., Glück, P., Kuo, C.-C., Schmitz, S., Nüchtern, S., Zenke, M., & Wagner, W. (2022) · Figshare · doi:10.6084/m9.figshare.20081040
Aberrant oxidative metabolism selects for TET2 -deficient hematopoietic stem and progenitor cellsPreprint
Niño, K. E., Ademà, V., Gray, A. E., Cowan, C. M., Schleicher, W. E., Hosseini, M., Bennett, S. N., Patel, S. B., Moreira, S., Danis, E. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.28.707294
Kolosova, E. D., Bogdanova, D. A., & Demidov, O. N. (2026) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2026-25-3-96-109
Schwengber, W. K., Sanders, J. W., Pinteric, A., Armitage, L., Childs, D. S., Halfdanarson, M. T. R., Patnaik, M. M., Martinez, F., Sonbol, M. B., & Kusne, Y. N. (2026) · Journal of Nuclear Medicine · doi:10.2967/jnumed.126.272210
Ünsal, Ş. E. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1943135
Metadata
- Authors
- Challen, G., & Goodell, M. A.
- Affiliations
- Washington University in St. Louis (US)
- Baylor College of Medicine (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2020-08-03
- Volume
- 136
- Issue
- 14
- Pages
- 1590-1598
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC7530644
- OpenAlex
- W3047537073
- Cited by
- 131
- References
- 95
- Citations by year
- 2026: 4 · 2025: 17 · 2024: 20 · 2023: 30 · 2022: 37 · 2021: 22 · 2020: 1
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- clonal hematopoiesis, hematopoietic stem cells, somatic mutations, aging, DNMT3A, TET2, epigenetic regulators, DNA damage response, stem cell self-renewal, stem cell differentiation, clonal dominance, recurrent mutations
- MeSH terms
- Discoidin Domain Receptors, Clonal Hematopoiesis, DNA Methyltransferase 3A, Animals, Cell Differentiation, DNA (Cytosine-5-)-Methyltransferases, DNA Damage, DNA-Binding Proteins, Hematopoiesis, Humans, Mutation, Proto-Oncogene Proteins, Stem Cells, Biomarkers, Gene Expression Regulation, Developmental, Dioxygenases, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
